Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adenovirus with mutations in the endoplasmic reticulum retention domain of the E3-19K protein and their use in cancer treatment

Adenovirus with mutations in the endoplasmic reticulum retention domain of the E3-19K protein and their use in cancer treatment

US Patent 8974777 · Granted Mar 10, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oncolytic adenoviruses for treating cancer2024
Methods of producing enriched populations of tumor reactive T cells from periphe2023
Methods of isolating T cells and T cell receptors having antigenic specificity f2023
Adenovirus comprising an albumin-binding moiety2023
Methods of producing enriched populations of tumor reactive T cells from periphe2020
Adenovirus comprising an albumin-binding moiety2020
Methods of isolating T cells and T cell receptors having antigenic specificity f2020
Oncolytic adenoviruses for treating cancer2019
Methods of producing enriched populations of tumor reactive T cells from periphe2017